ALTEOGEN Inc. (196170)
KRX
Closed
Aug 25, 2026
Day's Range
298,500.0052 wk Range
194,615.39Overview - 196170 - ALTEOGEN Inc.
Key Statistics
Valuation
Enterprise Value
21.95T
P/E (Trailing)
‪149.69‬
P/E (Forward)
‪56.25‬
PEG Ratio
‪-4.40‬
Price / Sales (TTM)
‪109.41‬
Price / Book
‪41.42‬
EV / EBITDA
‪236.32‬
Profitability
Gross Margin
‪85.93%‬
Profit Margin
‪63.89%‬
Operating Margin
‪54.89%‬
Return on Assets
‪7.71%‬
Return on Equity
‪25.22%‬
Ownership
Shares Outstanding
69.56M
Float
51.99M
Held by Insiders
‪33.40%‬
Held by Institutions
‪22.60%‬
Price stats
Beta
‪0.96‬
50-Day Avg
‪264,412.30‬
200-Day Avg
‪300,160.78‬
Dividends
Payout Ratio
‪10.35%‬
Analyst Consensus
6 analysts
Average price target
‪₩ 372,051.28‬Market Cap - 196170 - ALTEOGEN Inc.
Peers - 196170 - ALTEOGEN Inc.
Peer Comparison
Compared with companies in Biotechnology listed on KRX.
- 196170KRXALTEOGEN Inc.22.29TMarket Cap-5.12%52-week change157.05P/E (Trailing)‪63.89%‬Profit Margin
- 207940KRXSamsung Biologics Co., Ltd.72.81TMarket Cap+0.40%52-week change59.07P/E (Trailing)‪38.74%‬Profit Margin
- 068270KRXCelltrion Inc.44.48TMarket Cap+14.43%52-week change43.64P/E (Trailing)‪32.18%‬Profit Margin
- 0126Z0KRXSamsung Epis Holdings Co., Ltd.9.16TMarket Cap-19.00%52-week change—P/E (Trailing)‪33.89%‬Profit Margin
- 326030KRXSk Biopharmaceuticals Co., Ltd.6.76TMarket Cap-16.32%52-week change25.34P/E (Trailing)‪44.13%‬Profit Margin
- 028300KRXHLB Co., Ltd.5.08TMarket Cap+1.04%52-week change-22.80P/E (Trailing)‪-228.04%‬Profit Margin
- 214450KRXPharma Research Products Co., Ltd4.30TMarket Cap-69.84%52-week change26.08P/E (Trailing)‪31.21%‬Profit Margin
Profile Summary - 196170 - ALTEOGEN Inc.
About
ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars. The company develops ALT-P1, a long-acting human growth hormone that is in the Phase IIa clinical trial; and ALT-Q2, a long-acting active form of coagulation factor VII for the…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
